The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HIK HIKMA PHARMACEUTICALS PLC ORD SHS 10P




 Page 1 of 4

| 1 | 2 | 3 | 4 | Next

Time/Date Code Headline Source Impact
17:40 29-Apr-2016 HIK Director/PDMR Shareholding RNS -2.80% Down
14:58 28-Apr-2016 HIK Director/PDMR Shareholding RNS -2.57% Down
16:19 25-Apr-2016 HIK Director/PDMR Shareholding RNS -1.92% Down
16:22 22-Apr-2016 HIK Director/PDMR Shareholding RNS -
16:00 20-Apr-2016 HIK Director/PDMR Shareholding RNS +3.25% Up
16:14 19-Apr-2016 HIK Director/PDMR Shareholding RNS +4.86% Up
12:57 19-Apr-2016 HIK Director/PDMR Shareholding RNS +4.86% Up
10:02 12-Apr-2016 HIK Director/PDMR Shareholding RNS +5.28% Up
07:00 08-Apr-2016 HIK Update on ANDA for Generic Advair DiskusŪ RNS +5.14% Up
16:08 07-Apr-2016 HIK Director/PDMR Shareholding RNS +4.85% Up
11:41 07-Apr-2016 HIK Annual Information Update RNS +4.85% Up
10:54 07-Apr-2016 HIK Annual Financial Report RNS +4.85% Up
16:11 06-Apr-2016 HIK Blocklisting Interim Review RNS +5.24% Up
16:13 05-Apr-2016 HIK Director/PDMR Shareholding RNS +4.96% Up
17:37 31-Mar-2016 HIK Director/PDMR Shareholding RNS +4.63% Up
09:36 29-Mar-2016 HIK Director/PDMR Shareholding RNS +5.99% Up
14:54 21-Mar-2016 HIK Director/PDMR Shareholding RNS +3.73% Up
15:25 17-Mar-2016 HIK Director/PDMR Shareholding RNS +6.58% Up
07:00 16-Mar-2016 HIK Final Results RNS +6.98% Up
09:25 03-Mar-2016 HIK Notice of Results RNS -4.91% Down

 Page 1 of 4

| 1 | 2 | 3 | 4 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 13 Hanover Square, London, W1S 1HW, United Kingdom
Company website http://www.hikma.com
Market cap(in millions)* £ 5,276.06
Listing/Admission to trading 04 Nov 2005
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-May-16
FTSE index FTSE All-Share,FTSE 350 Low Yield,FTSE 250,FTSE All-Share (ex IT),FTSE 350 (ex IT),FTSE MID 250 (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment STMM
MiFID Status Regulated Market
Exchange market size 1,000
SEDOL B0LCW08
ISIN number GB00B0LCW083


Start trading your favourite asset CFDs!
Carries risk of capital loss



HIKMA share news analysis (HIK)